Effects of the use of functional electro-stimulation (FES) on the physiological cost, speed and capacity of gait after stroke

La caída de antepié y la disminución de la capacidad de flexión dorsal del tobillo durante la fase de balanceo de la marcha, es una importante alteración motora posterior al accidente cerebrovascular. La es-timulación eléctrica neuromuscular y/o la estimulación eléctrica funcional son ampliamente utilizados y consi-deradas eficaces en la rehabilitación de miembro su-perior o inferior del accidente cerebrovascular. Dada la alta prevalencia de pacientes con hemiplejía post ACV que concurren al Servicio de Rehabilitación del Hospi-tal Lencinas, es de interés estudiar los efectos de los posibles tratamientos para mejorar la marcha de estos pacientes. Objetivos: establecer los cambios en cuanto a velo-cidad de marcha e Índice de costo fisiológico, por el uso de electroestimulación funcional y por el efecto del entrenamiento, Establecer los efectos sobre la marcha de la electroestimulación funcional. Determinar la habi-lidad de la misma en pacientes con hemiplejía derecha e izquierda, y Describir el grado de satisfacción de los pacientes con el uso de EEF

Fulminant myocarditis parvovirus B19 related in a young woman

We present the case of a 18-year-old female with fulminant lymphocytic myocarditis caused by Parvovirus B19 (PVB19), successfully treated using temporary LVAD. In the literature there is no consensus on the surgical strategy. While some surgeons prefer to use a single device supporting only the LV, others prefer to start immediately with a biventricular supporting. At pre-procedural ultrasound evaluation, her anatomical features were not suitable for a percutaneous device such as the Impella. Thus, a temporary paracorporeal continuous flow LVAD was inserted. The heart recovery allowed LVAD removal 9 days after the implant

No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age

Background : we investigated the association between 9 polymorphisms of genes encoding hemostasis factors and myocardial infarction in a large sample of young patients chosen because they have less coronary atherosclerosis than older patients, and thus their disease is more likely to be related to a genetic predisposition to a prothrombotic state Methods and Results : this nationwide case-control study involved 1210 patients who had survived a first myocardial infarction at an age of 45 years who underwent coronary arteriography in 125 coronary care units and 1210 healthy subjects matched for age, sex, and geographical origin. None of the 9 polymorphisms of genes encoding proteins involved in coagulation (G-455A -fibrinogen: OR, 1.0; CI, 0.8 to 1.2; G1691A factor V: OR, 1.1; CI, 0.6 to 2.1; G20210A factor II: OR, 1.0; CI, 0.5 to 1.9; and G10976A factor VII: OR, 1.0; CI, 0.8 to 1.3), platelet function (C807T glycoprotein Ia: OR, 1.1; CI, 0.9 to 1.3; and C1565T glycoprotein IIIa: OR, 0.9; CI, 0.8 to 1.2), fibrinolysis (G185T factor XIII: OR, 1.2; CI, 0.9 to 1.6; and 4G/5G plasminogen activator inhibitor type 1: OR, 0.9; CI, 0.7 to 1.2), or homocysteine metabolism (C677T methylenetetrahydrofolate reductase: OR, 0.9; CI, 0.8 to 1.1) were associated with an increased or decreased risk of myocardial infarction Conclusions : this study provides no evidence supporting an association between 9 polymorphisms of genes encoding proteins involved in hemostasis and the occurrence of premature myocardial infarction or protection against it

Incertezza delle regole e processo amministrativo

Il diritto tra esigenze di fissit\ue0 e di flessibilit\ue0. Indici strutturali di flessibilit\ue0 fisiologica e meccanismi di fissit\ue0 nel sistema delle protezioni giurisdizionali